PR104

Asset

Hypoxia-activated prodrug converted to a DNA-crosslinking agent

Stage
Phase 1
Modality
Small molecule
Target
DNA damage response
1
Indication
555
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains3
  • Owner and partners1
  • Trials555
  • Evidence for its targets3
  • Competitors12

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets